微信公众号
News Center
News Center
2022-05-18
According to GLOBOCAN 2020 global cancer statistics, in 2020, the incidence of renal cell carcinoma ranked 14th among malignant tumors worldwide, lower than prostate cancer and bladder cancer of the urinary system, and the mortality rate ranked 15th. Recently, the "Guidelines for the Diagnosis and Treatment of Renal Cell Carcinoma (2022 Edition)" were released. This article summarizes parts of the etiology and clinical manifestations of renal cell carcinoma.
Learn More Details
2022-05-16
![[Science Popularization Time] Can breast hyperplasia become cancerous? Every woman should understand this question.](https://omo-oss-image.thefastimg.com/portal-saas/pg2024072315461374370/cms/image/1cd94647-1c59-4eaa-9114-70a6f73e9480.jpg "[Science Popularization Time] Can breast hyperplasia become cancerous? Every woman should understand this question.")
Clinically, 90% of breast lobular hyperplasia is simple hyperplasia, which has no clear relationship with breast cancer.
Learn More Details
2022-05-07
![[Science Popularization Time] How to interrupt the chain from superficial gastritis to gastric cancer?](https://omo-oss-image.thefastimg.com/portal-saas/pg2024072315461374370/cms/image/8d2f80a2-c9d3-410f-a4e7-dd0055d1d862.jpg "[Science Popularization Time] How to interrupt the chain from superficial gastritis to gastric cancer?")
Before being diagnosed with stomach cancer, we have 10 years to stop it.
Learn More Details
2022-04-25
On April 23-24, 2022, the CSCO Guidelines Conference was held as scheduled. Regardless of changes in the external environment, the Chinese Society of Clinical Oncology (CSCO) has never stopped advancing the industry and improving the standardized diagnosis and treatment of tumors in China. This guidelines conference covered updates and insightful interpretations of guidelines for major tumor types. In addition, multiple guidelines were issued in areas such as tumor metastasis and adverse reactions to tumor treatments, providing a basis for clinical work and standardized diagnosis and treatment.
Learn More Details
2022-04-24
![[Indicator Interpretation] The Diagnostic and Prognostic Value of P53 Immunohistochemistry in Cancer (Part One)](https://omo-oss-image.thefastimg.com/portal-saas/pg2024072315461374370/cms/image/6e19e945-2384-476e-ba43-17c79293f909.jpg "[Indicator Interpretation] The Diagnostic and Prognostic Value of P53 Immunohistochemistry in Cancer (Part One)")
In gene research, the P53 mutation is a shining star in the field of cancer research. As a tumor suppressor gene, it has become an increasingly popular research focus among scientists.
Learn More Details
2022-04-20
On April 2, 2022, the Planning, Development and Informatization Department of the National Health Commission issued the "Notice from the Office of the Healthy China Action Promotion Committee on Printing and Distributing the Key Work Points of Healthy China Action 2022".
Learn More Details